交易中 02-06 10:03:45 美东时间
+0.510
+1.33%
今日重点评级关注:HC Wainwright & Co.:维持Praxis Precision Medicine"买入"评级,目标价从340美元升至1245美元;HC Wainwright & Co.:维持Perspective Therapeutics"买入"评级,目标价从10美元升至12美元
02-02 14:15
Goldman Sachs analyst Alexander Blostein maintains Virtu Finl (NYSE:VIRT) with a Neutral and raises the price target from $36 to $40.
01-31 01:54
华盛资讯1月30日讯,Virtu Financial, Inc. Class A公布2025财年Q4业绩,公司Q4营收9.70亿美元,同比增长16.3%,归母净利润1.40亿美元,同比增长48.7%。
01-30 01:55
Virtu Financial shares are trading higher after the company reported better-tha...
01-29 21:56
Virtu Finl (NYSE:VIRT) just disclosed its Q4 earnings on Thursday, January 29, ...
01-29 20:08
Companies Reporting Before The Bell • MOGU (NYSE:MOGU) is estimated to report e...
01-29 19:11
今日重点评级关注:HC Wainwright & Co.:上调Tempest Therapeutics评级至"买入",目标价11美元;Guggenheim:维持Sportradar Gr"买入"评级,目标价从34美元升至35美元
01-23 19:46
Morgan Stanley analyst Michael Cyprys maintains Virtu Finl (NYSE:VIRT) with a Underweight and raises the price target from $35 to $36.
01-23 00:35
今日重点评级关注:HC Wainwright & Co.:维持Rezolve AI"买入"评级,目标价从10美元升至12美元;HC Wainwright & Co.:维持Largo"买入"评级,目标价从2.9美元升至3.1美元
01-15 16:10
Piper Sandler analyst Patrick Moley maintains Virtu Finl (NYSE:VIRT) with a Overweight and raises the price target from $51 to $54.
01-14 22:34